Gilead Sciences Announces Second Quarter and First Half 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/7/2026
- Nasdaq set to fall at open as DeepSeek's AI chip push rattles markets
- Oil gains after vessels attacked near Strait of Hormuz
- Citi says SpaceX stock has path to $900+ valuation. Here’s how
- Tesla stock target lifted at RBC on potential SpaceX merger
- Short squeezes more likely than widespread selling: Citi
- Rivian Automotive (RIVN) files for 75M share offering
- Rivian offers Q2 2026 revenue outlook, cash position grows
- Nokia OYJ (NOKIA:FH) (NOK) PT Raised to EUR14 at Kepler Cheuvreux
- Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
- Coursera plans layoffs after Udemy merger, estimates $8M-$11M in costs
Gilead Sciences (GILD) Misses Q2 EPS by 34c; Guides In-Line
July 30, 2020 4:03 PM EDTGilead Sciences (NASDAQ: GILD) reported Q2 EPS of $1.11, $0.34 worse than the analyst estimate of $1.45. Revenue for the quarter came in at $5.1 billion versus the consensus estimate of $5.31 billion.
GUIDANCE:
Gilead Sciences sees FY2020 EPS of $6.25-$7.65, versus the consensus of... More
